From the article referenced...
"The bottom line is, while this morning's commentary from Stock Market Media Group may have referenced data that was ten years old, it's still quite relevant, and encouraging."
Therefore, today's PR was very significant for shareholders who have been awaiting current preclinical results. With improved technology, Dr Von Hoff and his team designing the trials, we can expect that they are seeing similar, if not improved results from those conducted 10 years ago...
I think Dr Von Hoff also believed the 10 year old data to be relevant and that is why he contacted us...